Axplora

European CDMO formed from Novasep/PharmaZell merger. Specializes in peptide API manufacturing, GLP-1 therapies, and ADCs. €50M investment in peptide purification at Mourenx, France. 9 API manufacturing sites across Europe and India. 2,400+ employees serving 900+ customers.

Axplora is listed as a CDMO in the peptide supply chain, serving Europe markets from Germany / Europe. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.